Announcement Autonomix Medical, Inc., a known medical device company devoted to modernising the accurate nerve-focused treatments, have received an official patent right from the European Patent Office (EPO) with the Patent No. EP4230133 with the title ‘Controlled and Precise Treatment of Car...
Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared their platform has been rewarded. The financial reward from the National Institute of General Medical ...
Announcement Johnson & Johnson, the popular company, has completed its acquisition of Halda Therapeutics OpCo, Inc., a known clinical-level biotechnology company. Along with this acquisition, Johnson & Johnson will now have the authority to use Halda’s exclusive Regulated Induced Prox...
Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an update to announce for its ongoing Phase 3 REGAL trial. The trial assessed GPS as a capable maintenan...
Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it has received a patent right from the Australian Patent Office. The Australian Patent No. AU2022270084A...
Announcement WORK Medical Technology Group LTD, a well-known provider of medical devices in China, operates via its branch named Work (Hangzhou) Medical Treatment Equipment Co., Ltd and its other branches in China have announced an approval. An approval to its branch, Hunan Saitumofei Co., Ltd, to ...
Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its first-ever step in a vast localised fat reduction drug candidate. The candidate for CBL-514 for the...
Announcement GE Healthcare’s CEO Peter Arduini is molding a new chapter for the overall $20 billion in business gained over the year. GE Healthcare Technologies was first introduced as a standalone public company on the Nasdaq exchange. From then onwards, the stock has experienced a growth of...
Announcement Coforge Limited, a popular entity known as NIIT Technologies Limited, announced its acquisition of Encora. Encora is a California-based technology services company specialising in elevating advancement and innovation for businesses via its promising expertise in Cloud, Data and AI tech...
Announcement Morgan Stanley has cut its firm’s price to $4 from $5 for GoodRx (GDRX). GoodRx Holdings Inc. is one of the most affordable penny stocks to invest in. Morgan has maintained a consistent rate for shares of other companies. Learning the next year's overview for the Healthcare Servi...
